Provided by Tiger Fintech (Singapore) Pte. Ltd.

Eli Lilly

738.21
-50.8800-6.45%
Post-market: 717.01-21.1975-2.87%19:59 EDT
Volume:5.30M
Turnover:3.96B
Market Cap:699.82B
PE:63.04
High:768.27
Open:762.11
Low:734.70
Close:789.09
Loading ...

Eli Lilly (NYSE:LLY) Announces Positive Phase 2 Results For siRNA Therapy Amid 6% Quarterly Price Dip

Simply Wall St.
·
10 hours ago

Stocks to Watch: Eli Lilly, Novo Nordisk, Hims & Hers, Maxeon Solar Technologies

Dow Jones
·
Yesterday

Shares of Obesity Drug Makers Lower, Proposal For Medicare Coverage Dropped

Dow Jones
·
Yesterday

Tariffs Pose $46 Billion Risk to Pharmaceutical Industry -- Analysis

Dow Jones
·
Yesterday

Jim Cramer Says You Should ‘Stay Long’ Eli Lilly (LLY) Because of These Reasons

Insider Monkey
·
04 Apr

Shares of Some U.S. Drugmakers Down After Trump Says Pharmaceutical Sector Is 'Under Review' for Tariffs

THOMSON REUTERS
·
04 Apr

BUZZ-US drugmakers fall after Trump's new tariff warnings

Reuters
·
04 Apr

Guess, Simulations Plus And 3 Stocks To Watch Heading Into Friday

Benzinga
·
04 Apr

BRIEF-Sangamo Therapeutics Announces Capsid License Agreement With Lilly To Deliver Genomic Medicines For Diseases Of The Central Nervous System

Reuters
·
04 Apr

Shares of Sangamo Therapeutics Rally on Licensing Deal With Eli Lilly

Dow Jones
·
04 Apr

Sangamo Signs Capsid License Deal With Eli Lilly; Shares Rise After Hours

MT Newswires Live
·
04 Apr

Eli Lilly & Co. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
04 Apr

Sangamo Therapeutics Enters Capsid License Agreement With Lilly

Dow Jones
·
04 Apr

Sangamo: Agreement Grants Lilly Rights to Employ Co's Novel Proprietary Capsid, Stac-Bbb, for up to 5 Potential Disease Targets

THOMSON REUTERS
·
04 Apr

Sangamo Therapeutics Inc: Eligible to Earn up to $1.4 Bln in Additional Licensed Target Fees and Milestone Payments

THOMSON REUTERS
·
04 Apr

Sangamo Therapeutics Inc: Sangamo to Receive an $18 Mln Upfront License Fee

THOMSON REUTERS
·
04 Apr

Pharma Stocks Survive Market Rout on Tariff Exemption, but Uncertainty Continues

Reuters
·
03 Apr

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

Zacks
·
03 Apr

Adobe Pick of the Week at Smart Insider Following CFO's Stock Purchase

MT Newswires Live
·
03 Apr

Big Pharma Avoids Worst-Case Tariff Scenario -- WSJ

Dow Jones
·
03 Apr